Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials
JAMA Oncol 2021 Mar 04;[EPub Ahead of Print], M Javle, E Shacham-Shmueli, L Xiao, G Varadhachary, N Halpern, D Fogelman, B Boursi, S Uruba, O Margalit, RA Wolff, T GolanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.